Emergence of Streptococcus pneumoniae of serotype 19A in France: molecular capsular serotyping, antimicrobial susceptibilities, and epidemiology

Diagnostic Microbiology and Infectious Disease

Volumn 65, Issue 1, 2009, Pages 49-57

  Dortet, Laurent ^a   Ploy, Marie Cécile ^b   Poyart, Claire ^a   Raymond, Josette ^a  

^a Service de Bactériologie   (France)

^b LIMOGES UNIVERSITY HOSPITAL   (France)

Author keywords

Antimicrobial resistance; Epidemiology; Serotype 19A; Streptococcus pneumoniae

Indexed keywords

AMOXICILLIN; CEFOTAXIME; ERYTHROMYCIN; LATEX; PENICILLIN G; PRISTINAMYCIN; RIFAMPICIN;

ACUTE OTITIS MEDIA; ADOLESCENT; ADULT; AGED; AGGLUTINATION TEST; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; CHILD; CONTROLLED STUDY; FRANCE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MOLECULAR EPIDEMIOLOGY; NONHUMAN; PNEUMOCOCCAL INFECTION; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEROTYPE; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; FRANCE; HUMANS; INFANT; LATEX FIXATION TESTS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PNEUMOCOCCAL INFECTIONS; PREVALENCE; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; YOUNG ADULT;

EID: 68349086854     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2009.05.009     Document Type: Article

References (37)

1. Aguiar S.I., Serrano I., Pinto F.R., Melo-Cristino J., and Ramirez M. Changes in Streptococcus pneumoniae serotypes causing invasive disease with non-universal vaccination coverage of the seven-valent conjugate vaccine. Clin. Microbiol. Infect. 14 (2008) 835-843
2. AlonsoDeVelasco E., Verheul A.F., Verhoef J., and Snippe H. Streptococcus pneumoniae: virulence factors, pathogenesis, and vaccines. Microbiol. Rev. 59 (1995) 591-603
3. Beall B., McEllistrem M.C., Gertz Jr. R.E., Wedel S., Boxrud D.J., Gonzalez A.L., Medina M.J., Pai R., Thompson T.A., Harrison L.H., McGee L., and Whitney C.G. Pre- and postvaccination clonal compositions of invasive pneumococcal serotypes for isolates collected in the United States in 1999, 2001, and 2002. J. Clin. Microbiol. 44 (2006) 999-1017
4. Black S., Shinefield H., Fireman B., Lewis E., Ray P., Hansen J.R., Elvin L., Ensor K.M., Hackell J., Siber G., Malinoski F., Madore D., Chang I., Kohberger R., Watson W., Austrian R., and Edwards K. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr. Infect. Dis. J. 19 (2000) 187-195
5. Bogaert D., De Groot R., and Hermans P.W. Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect. Dis. 4 (2004) 144-154
6. Choi E.H., Kim S.H., Eun B.W., Kim S.J., Kim N.H., Lee J., and Lee H.J. Streptococcus pneumoniae serotype 19A in children, South Korea. Emerg. Infect. Dis. 14 (2008) 275-281
7. Dagan R., Melamed R., Muallem M., Piglansky L., Greenberg D., Abramson O., Mendelman P.M., Bohidar N., and Yagupsky P. Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine. J. Infect. Dis. 174 (1996) 1271-1278
8. De Lencastre H., and Tomasz A. From ecological reservoir to disease: the nasopharynx, day-care centres and drug-resistant clones of Streptococcus pneumoniae. J. Antimicrob. Chemother. 50 Suppl S2 (2002) 75-81
9. Farrell D.J., Klugman K.P., and Pichichero M. Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of 7-valent pneumococcal vaccine in the United States. Pediatr. Infect. Dis. J. 26 (2007) 123-128
10. Gehanno P., Panajotopoulos A., Barry B., Nguyen L., Levy D., Bingen E., and Berche P. Microbiology of otitis media in the Paris, France, area from 1987 to 1997. Pediatr. Infect. Dis. J. 20 (2001) 570-573
11. Gray B.M., Converse III G.M., and Dillon Jr. H.C. Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage, and infection during the first 24 months of life. J. Infect. Dis. 142 (1980) 923-933
12. Hammitt L.L., Bruden D.L., Butler J.C., Baggett H.C., Hurlburt D.A., Reasonover A., and Hennessy T.W. Indirect effect of conjugate vaccine on adult carriage of Streptococcus pneumoniae: an explanation of trends in invasive pneumococcal disease. J. Infect. Dis. 193 (2006) 1487-1494
13. Hausdorff W.P., Feikin D.R., and Klugman K.P. Epidemiological differences among pneumococcal serotypes. Lancet Infect. Dis. 5 (2005) 83-93
14. Henrichsen J. Six newly recognized types of Streptococcus pneumoniae. J. Clin. Microbiol. 33 (1995) 2759-2762
15. Hicks L.A., Harrison L.H., Flannery B., Hadler J.L., Schaffner W., Craig A.S., Jackson D., Thomas A., Beall B., Lynfield R., Reingold A., Farley M.M., and Whitney C.G. Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. J. Infect. Dis. 196 (2007) 1346-1354
16. Hsu K.K., and Pelton S.I. Heptavalent pneumococcal conjugate vaccine: current and future impact. Expert Rev. Vaccines 2 (2003) 619-631
17. Jacobs M.R., Good C.E., Bajaksouzian S., and Windau A.R. Emergence of Streptococcus pneumoniae serotypes 19A, 6C, and 22F and serogroup 15 in Cleveland, Ohio, in relation to introduction of the protein-conjugated pneumococcal vaccine. Clin. Infect. Dis. 47 (2008) 1388-1395
18. Jacobs M.R., Good C.E., Beall B., Bajaksouzian S., Windau A.R., and Whitney C.G. Changes in serotypes and antimicrobial susceptibility of invasive Streptococcus pneumoniae strains in Cleveland: a quarter century of experience. J. Clin. Microbiol. 46 (2008) 982-990
19. Jefferies J.M., Smith A., Clarke S.C., Dowson C., and Mitchell T.J. Genetic analysis of diverse disease-causing pneumococci indicates high levels of diversity within serotypes and capsule switching. J. Clin. Microbiol. 42 (2004) 5681-5688
20. Kuehn B.M. Benefits of newer vaccines lauded: multiresistant pneumococcal strains emerging. JAMA 298 (2007) 2123-2125
21. Kyaw M.H., Lynfield R., Schaffner W., Craig A.S., Hadler J., Reingold A., Thomas A.R., Harrison L.H., Bennett N.M., Farley M.M., Facklam R.R., Jorgensen J.H., Besser J., Zell E.R., Schuchat A., and Whitney C.G. Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N. Engl. J. Med. 354 (2006) 1455-1463
22. Lalitha M.K., Thomas K., Kumar R.S., and Steinhoff M.C. Serotyping of Streptococcus pneumoniae by coagglutination with 12 pooled antisera. J. Clin. Microbiol. 37 (1999) 263-265
23. Lexau C.A., Lynfield R., Danila R., Pilishvili T., Facklam R., Farley M.M., Harrison L.H., Schaffner W., Reingold A., Bennett N.M., Hadler J., Cieslak P.R., and Whitney C.G. Changing epidemiology of invasive pneumococcal disease among older adults in the era of paediatric pneumococcal conjugate vaccine. JAMA 294 (2005) 2043-2051
24. Mahjoub-Messai F., Doit C., Mariani-Kurkdjian P., Francois M., and Bingen E. Epidemiology of acute otitis media caused by Streptococcus pneumoniae: emergence of serotype 19A. Arch. Pediatr. 15 (2008) 1713-1716
25. Mavroidi A., Godoy D., Aanensen D.M., Robinson D.A., Hollingshead S.K., and Spratt B.G. Evolutionary genetics of the capsular locus of serogroup 6 pneumococci. J. Bacteriol. 186 (2004) 8181-8192
26. Mbelle N., Huebner R.E., Wasas A.D., Kimura A., Chang I., and Klugman K.P. Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine. J. Infect. Dis. 180 (1999) 1171-1176
27. McCormick A.W., Whitney C.G., Farley M.M., Lynfield R., Harrison L.H., Bennett N.M., Schaffner W., Reingold A., Hadler J., Cieslak P., Samore M.H., and Lipsitch M. Geographic diversity and temporal trends of antimicrobial resistance in Streptococcus pneumoniae in the United States. Nat. Med. 9 (2003) 424-430
28. Moore M.R., Gertz Jr. R.E., Woodbury R.L., Barkocy-Gallagher G.A., Schaffner W., Lexau C., Gershman K., Reingold A., Farley M., Harrison L.H., Hadler J.L., Bennett N.M., Thomas A.R., McGee L., Pilishvili T., Brueggemann A.B., Whitney C.G., Jorgensen J.H., and Beall B. Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005. J. Infect. Dis. 197 (2008) 1016-1027
29. Pai R., Gertz R.E., and Beall B. Sequential multiplex PCR approach for determining capsular serotypes of Streptococcus pneumoniae isolates. J. Clin. Microbiol. 44 (2006) 124-131
30. Pichichero M.E., and Casey J.R. Emergence of a multiresistant serotype 19A pneumococcal strain not included in the 7-valent conjugate vaccine as an otopathogen in children. JAMA 298 (2007) 1772-1778
31. Poehling K.A., Talbot T.R., Griffin M.R., Craig A.S., Whitney C.G., Zell E., Lexau C.A., Thomas A.R., Harrison L.H., Reingold A.L., Hadler J.L., Farley M.M., Anderson B.J., and Schaffner W. Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine. JAMA 295 (2006) 1668-1674
32. Raymond J., Le Thomas I., Moulin F., Commeau A., Gendrel D., and Berche P. Sequential colonization by Streptococcus pneumoniae of healthy children living in an orphanage. J. Infect. Dis. 181 (2000) 1983-1988
33. Singleton R.J., Hennessy T.W., Bulkow L.R., Hammitt L.L., Zulz T., Hurlburt D.A., Butler J.C., Rudolph K., and Parkinson A. Invasive pneumococcal disease caused by nonvaccine serotypes among Alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. JAMA 297 (2007) 1784-1792
34. Stephens D.S., Zughaier S.M., Whitney C.G., Baughman W.S., Barker L., Gay K., Jackson D., Orenstein W.A., Arnold K., Schuchat A., and Farley M.M. Incidence of macrolide resistance in Streptococcus pneumoniae after introduction of the pneumococcal conjugate vaccine: population-based assessment. Lancet 365 (2005) 855-863
35. van de Sande-Bruinsma N., Grundmann H., Verloo D., Tiemersma E., Monen J., Goossens H., and Ferech M. Antimicrobial drug use and resistance in Europe. Emerg. Infect. Dis. 14 (2008) 1722-1730
36. Whitney C.G., Farley M.M., Hadler J., Harrison L.H., Bennett N.M., Lynfield R., Reingold A., Cieslak P.R., Pilishvili T., Jackson D., Facklam R.R., Jorgensen J.H., and Schuchat A. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N. Engl. J. Med. 348 (2003) 1737-1746
37. Whitney C.G., Pilishvili T., Farley M.M., Schaffner W., Craig A.S., Lynfield R., Nyquist A.C., Gershman K.A., Vazquez M., Bennett N.M., Reingold A., Thomas A., Glode M.P., Zell E.R., Jorgensen J.H., Beall B., and Schuchat A. Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study. Lancet 368 (2006) 1495-1502